Related Articles
Proteomic analysis of imatinib-resistant CML-T1 cells reveals calcium homeostasis as a potential therapeutic target
TOPK is regulated by PP2A and BCR/ABL in leukemia and enhances cell proliferation
BCR-ABL- and Ras-independent activation of Raf as a novel mechanism of Imatinib resistance in CML
Homoharringtonine promotes BCR‑ABL degradation through the p62‑mediated autophagy pathway
A novel compound against oncogenic Aurora kinase A overcomes imatinib resistance in chronic myeloid leukemia cells